Betel Pharmaceutical: Shareholder Kaiming Investment has released the pledge of 11.65 million shares.

Bera Pharmaceutical announced that shareholder Kaiming Investment has had a change in the pledge of part of the company's shares, with a total of 11.6519 million shares released from pledge on June 4, 2026, accounting for 14.55% of its holdings and 2.77% of the company's total share capital. As of the disclosure date of the announcement, the cumulative pledged shareholding of Kaiming Investment and its concerted action parties accounted for 55.45% of their holdings in the company. This change does not involve new financing, and the controlling shareholder and its concerted action parties have the ability to repay funds, with the overall risk of the pledge being controllable.